Citigroup’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.58K Buy
11,837
+11,836
+1,183,600% +$10.2K ﹤0.01% 5058
2025
Q4
$1 Sell
1
-5,844
-100% -$5.28K ﹤0.01% 5959
2025
Q3
$5.76K Buy
+5,845
New +$5.29K ﹤0.01% 5197
2022
Q3
Sell
-25
Closed -$1K 5836
2022
Q2
$1K Sell
25
-75
-75% -$4.55K ﹤0.01% 5982
2022
Q1
$7K Buy
+100
New +$7.25K ﹤0.01% 5670

Other funds holding BFRI

Citigroup's BFRI Position: Q1 2026 in Review

Citigroup increased its Biofrontera (BFRI) stake by 1,183,600% in Q1 2026, buying an estimated $10.2K and bringing the position to 11,837 shares worth $9.58K. The position accounts for ﹤0.01% of the portfolio, ranked #5058.

Citigroup first reported a position in BFRI in Q1 2022 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • Citigroup held 11,837 shares of Biofrontera worth $9.58K as of Q1 2026.
  • Citigroup bought 11,836 Biofrontera shares in Q1 2026, an estimated $10.2K.
  • Biofrontera made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5058 holding.
  • Citigroup first reported a position in Biofrontera in Q1 2022 and has held it in 5 quarters since.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.